0001127602-23-013930.txt : 20230501
0001127602-23-013930.hdr.sgml : 20230501
20230501174333
ACCESSION NUMBER: 0001127602-23-013930
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230428
FILED AS OF DATE: 20230501
DATE AS OF CHANGE: 20230501
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NABEL ELIZABETH G
CENTRAL INDEX KEY: 0001619929
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38753
FILM NUMBER: 23875506
MAIL ADDRESS:
STREET 1: BRIGHAM AND WOMEN'S HOSPITAL
STREET 2: 75 FRANCIS ST
CITY: BOSTON
STATE: MA
ZIP: 02115
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Moderna, Inc.
CENTRAL INDEX KEY: 0001682852
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813467528
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 6177146500
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Moderna Therapeutics, Inc.
DATE OF NAME CHANGE: 20160822
4
1
form4.xml
PRIMARY DOCUMENT
X0407
4
2023-04-28
0001682852
Moderna, Inc.
MRNA
0001619929
NABEL ELIZABETH G
C/O MODERNA, INC.
200 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
1
0
Common Stock
2023-04-28
4
M
0
670
A
1373
D
Restricted Stock Units
2023-04-28
4
M
0
670
0
D
Common Stock
670
0
D
Restricted stock units convert into common stock on a one-for-one basis.
The shares subject to this restricted stock unit award vested in full on April 28, 2023.
/s/ Brian Sandstrom, as Attorney-in-Fact
2023-05-01